Company overview
Eli Lilly is a global pharmaceutical company focused on diabetes and obesity, oncology, immunology and neuroscience. Its GLP-1 based medicines for diabetes and weight management have become major growth drivers.
Like other drugmakers, Lilly's results depend on its research pipeline, regulatory approvals and patent protection.
Company facts
Sector
Healthcare
Industry
Drug Manufacturers - General
Headquarters
Indianapolis, Indiana
Exchange
NYSE
Share price
Market cap
P/E ratio (TTM)
Dividend yield
52-week range
Competitors to compare
NVO,MRK,PFE,ABBV
Keep researching
Data is provided by our market data partner and may be delayed. StockEngine is not investment advice.